Page last updated: 2024-10-28

gr 89696 and Depressive Disorder, Major

gr 89696 has been researched along with Depressive Disorder, Major in 1 studies

GR 89696: a potent & selective kappa opioid receptor agonist; RN given refers to (E)-2-butenedioate(1:1); RN for parent cpd not available 11/92; GR 103545 is the (R)-isomer

Depressive Disorder, Major: Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miller, JM1
Zanderigo, F1
Purushothaman, PD1
DeLorenzo, C1
Rubin-Falcone, H1
Ogden, RT1
Keilp, J1
Oquendo, MA1
Nabulsi, N1
Huang, YH1
Parsey, RV1
Carson, RE1
Mann, JJ1

Other Studies

1 other study available for gr 89696 and Depressive Disorder, Major

ArticleYear
Kappa opioid receptor binding in major depression: A pilot study.
    Synapse (New York, N.Y.), 2018, Volume: 72, Issue:9

    Topics: Adolescent; Adult; Analgesics, Opioid; Brain; Depressive Disorder, Major; Humans; Image Processing,

2018